首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1369篇
  免费   106篇
  国内免费   7篇
耳鼻咽喉   5篇
儿科学   88篇
妇产科学   13篇
基础医学   154篇
口腔科学   51篇
临床医学   194篇
内科学   242篇
皮肤病学   24篇
神经病学   79篇
特种医学   283篇
外科学   107篇
综合类   38篇
一般理论   1篇
预防医学   44篇
眼科学   20篇
药学   60篇
中国医学   5篇
肿瘤学   74篇
  2023年   9篇
  2022年   3篇
  2021年   9篇
  2020年   7篇
  2019年   13篇
  2018年   24篇
  2017年   14篇
  2016年   22篇
  2015年   25篇
  2014年   31篇
  2013年   34篇
  2012年   51篇
  2011年   44篇
  2010年   48篇
  2009年   66篇
  2008年   48篇
  2007年   37篇
  2006年   42篇
  2005年   25篇
  2004年   28篇
  2003年   33篇
  2002年   26篇
  2001年   33篇
  2000年   33篇
  1999年   24篇
  1998年   55篇
  1997年   54篇
  1996年   65篇
  1995年   50篇
  1994年   52篇
  1993年   50篇
  1992年   20篇
  1991年   19篇
  1990年   24篇
  1989年   42篇
  1988年   41篇
  1987年   41篇
  1986年   38篇
  1985年   30篇
  1984年   18篇
  1983年   12篇
  1982年   23篇
  1981年   19篇
  1980年   15篇
  1979年   11篇
  1978年   7篇
  1977年   18篇
  1976年   20篇
  1975年   14篇
  1971年   3篇
排序方式: 共有1482条查询结果,搜索用时 15 毫秒
1.
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma.  相似文献   
2.
We describe 2 renal transplant patients with increasing plasma creatinine levels after resolution of acute rejection episodes. Antegrade pyelography demonstrated adherence of the ureter to the inferior pole of the kidney with partial obstruction in both cases, which was confirmed at operation.  相似文献   
3.
It is known that low glucose concentrations increase the aspartate and decrease the glutamate content of brain tissue both in vivo and in vitro. To see whether these changes occur in the transmitter compartment or not, the release of aspartate and glutamate evoked by electrical-field stimulation or by high K+ was followed in slices of rat hippocampus superfused with 5 or 0.2 mM glucose. Superfusion with 0.2 mM glucose increased the evoked release of aspartate about ten times and that of glutamate about threefold. This shift in the ratio of aspartate to glutamate released was accompanied by a similar increase in the relative amount of aspartate contained in the slices. The high evoked release of aspartate and glutamate was well maintained, provided 0.5 mM glutamine was added to the medium. Changing the concentration of glucose after the first period of stimulation rapidly altered the relative amounts of aspartate and glutamate released but not the enhanced release of glutamate. The large evoked release of both aspartate and glutamate in 0.2 mM glucose was almost entirely Ca2+-dependent. The relative amounts of aspartate and glutamate released by 50 mM K+ also changed when the glucose concentration was reduced. Results suggest two effects of low glucose concentrations: an increase in the overflow of synaptically released glutamate due to a decreased uptake and an increase in the proportion of aspartate to glutamate formed and released from the transmitter pool. These observations are consistent with the interpretation that these two transmitters can be released in different proportions from the same terminals.  相似文献   
4.
5.
6.
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号